Neuphoria Therapeutics(NEUP)
$2.71+0.02 (+0.74%)
NEUP
Neuphoria Therapeutics financials statements
$2.71
At close:+0.02 (+0.74%)
Want to see NEUP full AI Analyst Report?
Neuphoria Therapeutics (NEUP) Income Statement
301 Followers
Neuphoria Therapeutics Income Statement
Last quarter (Q4 2026), Neuphoria Therapeutics's total revenue was AU$1.17M, an increase of 111.21% from the same quarter last year. In Q4, Neuphoria Therapeutics's net income was AU$-4.90M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 1.17M | AU$ 15.65M | AU$ 0.00 | AU$ 0.00 | AU$ 383.16K | |
| AU$ 511.21K | AU$ 14.99M | AU$ -662.99K | AU$ -671.48K | AU$ -9.98M | |
| AU$ 10.32M | AU$ 16.12M | AU$ 17.89M | AU$ 33.09M | AU$ 23.74M | |
| Depreciation and Amortization | AU$ 662.96K | AU$ 662.89K | AU$ 662.99K | AU$ 970.68K | AU$ 1.11M |
| AU$ -9.15M | AU$ -466.20K | AU$ -25.98M | AU$ -31.48M | AU$ -30.75M | |
| AU$ -9.81M | AU$ -1.13M | AU$ -26.79M | AU$ -33.09M | AU$ -31.02M | |
| AU$ -3.78M | AU$ 291.09K | AU$ 2.31M | AU$ 695.55K | AU$ -886.03K | |
| AU$ -13.59M | AU$ -838.00K | AU$ -15.58M | AU$ -32.39M | AU$ -31.90M | |
| AU$ -13.45M | AU$ -369.63K | AU$ -15.49M | AU$ -32.18M | AU$ -22.94M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -3.06 | AU$ -0.23 | AU$ -0.10 | AU$ -0.24 | AU$ -0.20 |
| Diluted EPS | AU$ -3.06 | AU$ -0.23 | AU$ -0.10 | AU$ -0.24 | AU$ -0.20 |
| Weighted Average Shares Outstanding | 4.40M | 1.62M | 149.80M | 122.39M | 112.78M |
| Weighted Average Shares Outstanding (Diluted) | 4.40M | 1.62M | 149.80M | 122.39M | 112.78M |
Currency in AUD
